¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"area monitoring"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
area monitoring
±¸¿ª°¨½Ã
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
air monitoring
´ë±â°¨½Ã
blood glucose monitoring
Ç÷´ç°¨½Ã
central venous pressure monitoring
Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
drug level monitoring
¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
fetal monitoring
žư¨½Ã, žƸð´ÏÅ͸µ
hemodynamic monitoring
Ç÷¿ªÇа¨½Ã, Ç÷¿ªÇиð´ÏÅ͸µ
invasive monitoring
ħ½À°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
intraoperative monitoring
¼ö¼úÁß°¨½Ã
monitoring
°¨½Ã, ¸ð´ÏÅ͸µ
metabolic monitoring
´ë»ç·®Á¶»ç
neuromuscular monitoring
½Å°æ±Ù(À°)°¨½Ã
noninvasive monitoring
ºñħ½À°¨½Ã
personal monitoring
1. °³Àΰ¨½Ã 2. °³Àμ±·®°¨½Ã
quality monitoring
Áú°¨½Ã
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
10
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
monitoring
°¨½Ã
therapeutic drug monitoring
Ä¡·á¾à¹°³óµµ°¨½Ã
area
±¸¿ª, ¿µ¿ª, ¿ª, ºÎÀ§, ºÎ, ¸éÀû
area cribrosa
ü±¸¿ª
area postrema
¸Ç¾Æ·¡±¸¿ª
inguinal area
»ô±¼ºÎÀ§, ¼ÇýºÎ
preoptic area
½Ã°¢±³Â÷¾Õ±¸¿ª
subareolar area
Á¥²ÉÆÇ¹ØºÎÀ§, À¯·ûÇϺÎ
supporting area
ÁöÁöºÎ
surface area
üǥ¸éÀû, Ç¥¸éÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
area monitoring
±¸¿ª°¨½Ã
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
air monitoring
´ë±â°¨½Ã
central venous pressure monitoring
Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
chemotherapeutic drug monitoring
ÈÇпä¹ý¾àÁ¦°¨½Ã
drug level monitoring
¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
fetal monitoring
žư¨½Ã
glucose monitoring
Æ÷µµ´ç°¨½Ã
heparin therapy monitoring
ÇìÆÄ¸°¿ä¹ý°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
intraoperative monitoring
¼ö¼úÁß°¨½Ã
invasive monitoring
ħ½À°¨½Ã
monitoring
°¨½Ã
metabolic monitoring
´ë»ç·®Á¶»ç
neuromuscular monitoring
½Å°æ±ÙÀ°°¨½Ã
noninvasive monitoring
ºñħ½À°¨½Ã
personal monitoring
°³À਽Ã, °³Àμ±·®°¨½Ã
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
area monitoring
±¸¿ª<¹æ»çÇÇÆø>°¨½Ã.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
TDM : therapeutic drug monitoring
Ä¡·á¾à¹°³óµµ ¸ð´ÏÅ͸µ.
air monitoring
´ë±â¿À¿°°¨½Ã(ËÀË»ËçËç˧Ëà).
glucose monitoring
Æ÷µµ´ç°¨½Ã
heparin therapy monitoring
ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
personal monitoring
°³ÀÎ (ÇÇÆø)°¨½Ã
personal monitoring
°³Àμ±·®°¨½Ã
quality monitoring
Á¤µµ°ü¸®°¨½Ã
radiation monitoring
¹æ»ç¼±°¨½Ã
AUC : area under the concentration-time curve
Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
Brocas area
ºê·ÎÄ«¿µ¿ª.
Brocas area
ºê·ÎÄ«¿µ¿ª
Brocas speech area
ºê·ÎÄ«¾ð¾î¿µ¿ª
Brodmanns area
ºê·Îµå¸¸ ¿µ¿ª(çÐæ´)
Frontal association area
ÀüµÎ¿¬ÇÕ¾ß(îñÔéÖ¤ùêå¯)
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
area monitoring
±¸¿ª<¹æ»çÇÇÆø>°¨½Ã.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cochlear area, =area cochleae <³ª>
¿Í¿ì¿µ¿ª, ´ÞÆØÀ̽Ű汸¿ª{ÇØ}
cochlear area<³ª> area cochleae
´ÞÆØÀ̽Ű汸¿ª, ¿Í¿ì¾ß(èÄéÚå¯).
supplemental motor area = supplementary area
º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´)
air monitoring
´ë±â¿À¿°°¨½Ã(ËÀË»ËçËç˧Ëà).
behavior monitoring program
Çൿ(ÇàÅÂ)°¨½ÃÇÁ·Î±×·¥
chemotherapeutic drug monitoring
ÈÇпä¹ý¾àÁ¦°¨½Ã
drug level monitoring
¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
fetal monitoring
žư¨½Ã.
glucose monitoring
Æ÷µµ´ç°¨½Ã
heparin therapy monitoring
ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
invasive monitoring
°üÇ÷Àû °¨½Ã.
metabolic monitoring
´ë»ç·®Á¶»ç(¡åÖðàÞÛ).
monitoring
°¨½Ã
neuromuscular monitoring
½Å°æ±Ù°¨½Ã
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½